Mycotoxin Testing Market - Global Forecast 2025-2032

The mycotoxin testing market is evolving rapidly as regulatory frameworks intensify and expectations for product safety rise across food, feed, and pharmaceutical sectors. Senior executives must stay equipped with relevant intelligence to foster compliance, operational strength, and informed risk management in an increasingly complex environment.

Market Snapshot: Mycotoxin Testing Market

The global mycotoxin testing market is experiencing significant expansion, growing from USD 2.67 billion in 2024 to USD 2.88 billion in 2025, and is projected to maintain a robust CAGR of 7.92%, reaching USD 4.93 billion by 2032. This momentum is driven by increasing attention to food and feed safety, stricter regulatory oversight, and greater global recognition of contamination risks. Corporate leaders are adapting by embracing advanced laboratory solutions, investing in future-ready quality assurance frameworks, and aligning operations to heightened compliance requirements. The market's upward trajectory reflects a growing adoption of sophisticated testing methods across critical geographies and supply chains.

Scope & Segmentation

This comprehensive report offers senior leadership clear visibility into the mycotoxin testing landscape, providing tools for benchmarking, investment planning, and operational improvement. With detailed segmentation, organizations can tailor market entry, partnership strategies, and technology adoption according to industry needs.

• Testing Techniques: Enzyme Linked Immunosorbent Assay (ELISA, including both direct and sandwich formats), High Performance Liquid Chromatography (with fluorescence and UV detection), Liquid Chromatography Mass Spectrometry (including high resolution LC MS and triple quadrupole LC MS/MS), Polymerase Chain Reaction (quantitative and reverse transcriptase PCR), Rapid Test Kits (fluorescence polarization immunoassay, lateral flow assay).
• Toxin Types: Aflatoxin, Fumonisin, Ochratoxin, Trichothecenes, Zearalenone.
• Sample Types: Animal Feed (covering mash, pellets, premix), Cereals & Grains (barley, maize, oats, rice, wheat), Dairy Products (such as cheese, milk, yogurt), Fruits & Vegetables (including apples, grapes, tomatoes), Nuts & Seeds (almonds, peanuts, walnuts), Spices & Herbs (cinnamon, pepper, turmeric).
• End Users: Animal Feed (e.g., compound feed producers, feed mills), Environmental Testing (soil and water labs), Food & Beverage (covering bakery, beverages, and dairy processors), Pharmaceutical (including drug formulation and quality control), Research Institutes.
• Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe (UK, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East (UAE, Saudi Arabia, Qatar, Turkey, Israel), Africa (South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
• Company Profiles: Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Eurofins Scientific SE, Mérieux NutriSciences Corporation, Romer Labs Division Holding, Waters Corporation, SGS SA, RealTime Laboratories, TUV INDIA PVT LIMITED, Neogen Corporation.

Key Takeaways

• Continued advancements in high-resolution mass spectrometry and digital data management are enabling more precise, rapid, and adaptable testing across a diverse set of environments.
• Shifting global regulatory measures are prompting manufacturers and laboratories to integrate agile risk management tools, such as real-time analytics, to better align with updated standards and reduce compliance gaps.
• Multiplexed testing and multi-toxin screening are supporting laboratories in managing increasing contamination complexity, ensuring reliable assessment across growing commodity categories and regions.
• Collaboration between public and private sectors is enabling the development of validated test methods, fostering harmonized industry practices, and establishing networks for ongoing operational learning and best-practice transfer.
• Segment-specific testing approaches are essential, as different matrices—such as cereals, dairy, spices, environmental samples, and pharmaceutical ingredients—require tailored protocols suited to varying levels of market maturity.
• Modernization of infrastructure and supply chain resilience, particularly in fast-developing markets, is closely linked to emerging regulatory drivers and the unlocking of new commercial opportunities.

Tariff Impact

Recent changes in U.S. tariff policy have increased import duties on essential laboratory consumables and diagnostic instruments used for mycotoxin testing. These changes are resulting in higher costs and delays across supply channels, directly impacting testing throughput and affordability. Stakeholders are responding by renegotiating supplier agreements, investing in local and regional manufacturing capabilities, and optimizing workflows to maintain cost-effectiveness and operational continuity.

Methodology & Data Sources

This analysis utilizes a mixed-methods research model, comprising in-depth interviews with laboratory heads, regulatory authorities, and quality managers globally. Targeted surveys and structured expert panels provide supplemental insights, with all findings cross-validated against peer-reviewed publications, regulatory documents, and technical white papers to enhance depth and reliability.

Why This Report Matters

• Equips senior decision-makers with practical guidance on navigating technology adoption, shifting regulatory obligations, and complex risk landscapes within the mycotoxin testing industry.
• Enables precise strategic planning by mapping evolving regulatory policies, competitor activity, and end-user demands across segments and regions.
• Supports robust business cases for market expansion, operational investment, and innovation-driven growth through clear forecasts and actionable market intelligence.

Conclusion

Grounded in rigorous research and actionable insight, this report provides executives with the clarity needed to drive compliance, strengthen risk mitigation strategies, and cultivate sustained growth in the mycotoxin testing sector.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.